Controlled-Substance Prescribing Policies for Telepsychiatry Practices: What Your Policy Should Cover
A telepsychiatry controlled substance policy should give the practice a consistent way to handle prescribing decisions before routine or unusual requests arise. It should define who makes those decisions, what needs to be checked, how PMP and EPCS enter the workflow, when a request needs clinical reassessment, and what should be documented.
Some requirements come from federal or New York law. Others are rules the practice chooses, such as how patients submit routine requests or what happens when medication is lost. Keeping those categories separate makes the policy easier to update.
This guide focuses on that internal policy structure.
What Should a Telepsychiatry Controlled-Substance Prescribing Policy Cover?
A useful policy should define the practice's decision process from the first prescription through routine follow-up, patient communication, refill requests, exceptions, escalation, emergencies, and periodic review.
| Policy area | What the practice should define |
|---|---|
| Prescribing authority | Who evaluates the patient, makes the prescribing decision, and signs the prescription |
| Patient verification | How identity, current location, and relevant contact information are confirmed |
| Consent and patient communication | What prescribing expectations, risks, practice procedures, and patient responsibilities need to be communicated or documented |
| Telemedicine eligibility | How the clinician confirms that remote prescribing is permitted for the encounter |
| In-person evaluation | How the practice determines whether an in-person evaluation is required or clinically indicated |
| Monitoring | Follow-up expectations, reassessment triggers, and any patient-specific monitoring plan |
| PMP and EPCS | When PMP review occurs and how the EPCS process enters the workflow |
| Medication requests | Procedures for routine renewals, early requests, travel, lost medication, and pharmacy changes |
| Escalation and urgent situations | When a request leaves the routine workflow and requires clinical reassessment, urgent response, or higher-level care |
| Documentation and review | What decisions are recorded and when the policy itself is reviewed |
Which Parts of a Controlled-Substance Policy Come From Law, and Which Come From the Practice?
A prescribing policy combines legal requirements with clinical and administrative rules chosen by the practice, and those categories should be labeled accurately.
Federal and New York requirements govern telemedicine prescribing, PMP consultation, electronic prescribing, prescription timing, and recordkeeping. Practice-created rules can address request channels, lost or stolen medication, travel, appointment expectations, and exception review.
Federal law prohibits refills of Schedule II prescriptions. A statement such as "our practice does not automatically replace lost controlled medication" is different. That is an internal rule that preserves clinical review. The written policy should identify the source of each requirement instead of calling every boundary "DEA policy."
What Should the Policy Require Before a Telemedicine Controlled-Substance Prescription Is Issued?
The policy should require the prescriber to confirm that the encounter and proposed prescription are legally permitted and clinically appropriate before the medication workflow moves forward.
For a New York telepsychiatry practice, that means having a defined process for confirming:
the patient's identity;
the patient's current location at the time of the encounter;
the practitioner's authority to treat and prescribe for that patient;
whether the current encounter can support controlled-substance prescribing under federal and New York rules;
whether an in-person evaluation has occurred or an applicable exception permits prescribing without one;
whether an in-person assessment is clinically indicated based on the patient's condition and treatment plan.
New York's current rule states that a controlled substance may not be prescribed before an in-person medical evaluation unless an exception applies. One listed exception permits qualifying telemedicine or telehealth prescribing when it is consistent with New York law and applicable DEA rules. The rule took effect May 21, 2025.
At the federal level, DEA and HHS have extended the current temporary telemedicine flexibilities through December 31, 2026. Those flexibilities can permit DEA-registered practitioners to prescribe Schedule II-V controlled medications through qualifying telemedicine encounters without a prior in-person medical evaluation, subject to federal requirements and applicable state law.
The policy should identify temporary federal authority by date.
How Should PMP, EPCS, Monitoring, and Documentation Fit Into the Policy?
The policy should define when each dependency enters the prescribing process and who is responsible.
For PMP/I-STOP, the policy should identify when the prescriber reviews the controlled substance history of the patient. In New York, most prescribers must consult the PMP Registry when writing prescriptions for Schedule II, III, and IV controlled substances unless an applicable exception applies. New York PMP/I-STOP for PMHNPs and Psychiatrists covers the search mechanics and exception details.
For EPCS, the policy should identify who can issue the prescription and how the request reaches that person. New York mandates electronic prescribing of controlled and noncontrolled substances, with defined exceptions. The technical setup itself is covered in EPCS for PMHNPs and Psychiatrists in New York.
Monitoring should remain patient specific. The policy can define follow up expectations and escalation triggers without inventing a universal visit or testing schedule. Documentation should capture the reasoning and plan, and DEA Recordkeeping for Telehealth Psychiatrists and PMHNPs walks through retention and record location rules in full.
What Should the Policy Say About Refills and Unusual Medication Requests?
The policy should explain how routine medication requests are submitted and how exceptions are reviewed without promising an automatic outcome.
| Situation | Policy should define |
|---|---|
| Routine renewal | Request channel, expected notice, appointment status, required clinical review |
| Early request | Reason for the request, remaining supply, PMP review where required, prior pattern, prescriber decision |
| Lost or stolen medication | Information to collect, possible supporting documentation, clinical risk, prior history, no automatic replacement |
| Travel | Advance notice, medication timing, destination, pharmacy feasibility, applicable legal limits |
| Pharmacy change or transmission problem | Status of the original prescription and steps to avoid unintended duplicate active prescriptions |
Under 21 CFR ยง1306.12, a prescription for a Schedule II controlled substance may not be refilled. Continued treatment requires a new prescription, even when patients or staff use the word "refill" conversationally.
New York has separate rules for Schedule III, IV, and V prescriptions. Section 80.69 governs refill limits and timing for those schedules, so a practice should avoid using one refill rule for every controlled medication.
Lost medication, travel, or a pharmacy shortage may call for added assessment. The request itself does not establish misuse and does not guarantee replacement.
When Should a Medication Request Trigger Clinical Reassessment or Escalation?
A request should leave the routine administrative workflow when the pattern or clinical circumstances raise questions about safety, adherence, coordination, continuity, or whether the treatment plan remains appropriate.
Potential triggers include repeated early requests, repeated reports of lost medication, overlapping prescriptions or prescribers, unexpected PMP findings, unauthorized dose changes, missed follow-up, inability to complete needed monitoring, possible diversion, or a meaningful risk from abrupt medication interruption.
An escalation trigger is a reason to assess the situation, not proof that the patient has done something wrong. The policy should define when staff route the request to the clinician and what gets reviewed.
Urgent situations need a separate path. Possible withdrawal, acute deterioration, immediate safety concerns, or a need for emergency or higher-level care should leave the ordinary refill workflow. The policy does not need to prescribe one clinical response for every case. It needs to define how the situation is recognized, routed, and documented.
The policy should keep medication decisions, broader treatment-plan changes, and termination of the treatment relationship separate.
Who Handles Controlled-Medication Requests Inside the Practice?
Administrative staff can receive and route controlled-medication requests, but the prescribing decision belongs to the authorized clinician.
Staff may receive a request through the approved channel, confirm medication and pharmacy information, check appointment status, schedule follow-up, and route unusual or urgent circumstances.
The prescriber remains responsible for PMP interpretation, clinical assessment, the prescribing decision, dose and quantity, and completion of the controlled-substance prescription. The practice should use one reliable communication path for intake, triage, and documentation.
Should the Practice Have Both an Internal SOP and a Patient-Facing Medication Policy?
Yes. The internal SOP can contain operational detail, and the patient-facing policy can state expectations in plain language.
The internal SOP may cover staff roles, PMP and EPCS checkpoints, documentation, escalation, urgent routing, and exception handling. The patient-facing version can explain request channels, notice, follow-up, travel, lost medication, pharmacy changes, other prescribers, and what the patient should do when a medication issue becomes urgent.
The practice can document how medication risks, follow-up responsibilities, refill procedures, monitoring expectations, and added-review triggers are communicated and acknowledged.
A concise patient-facing statement might read:
Controlled medications require ongoing clinical review. Please submit routine medication requests through the practice's designated channel with enough time for review and keep scheduled follow-up appointments. Early, lost, stolen, travel-related, or pharmacy-change requests are reviewed individually and may require added information or an appointment. Approval is not automatic. If a medication issue is urgent or involves an immediate safety concern, follow the practice's urgent-care instructions rather than relying on the routine refill channel.
How Often Should a Controlled-Substance Prescribing Policy Be Reviewed?
The practice should review the policy on a defined internal schedule and whenever a material legal, clinical, technical, staffing, or operational change affects the prescribing workflow.
A review may be needed after a change to federal telemedicine authority, New York Part 80, PMP or EPCS requirements, staffing, communication systems, or follow-up procedures. A policy written in September 2026 should identify December 31, 2026 as the current federal endpoint rather than treating the present temporary rules as permanent.
A practice may choose an annual full review plus more frequent regulatory checks. That cadence is an internal governance decision unless another rule sets a requirement.
How Can CHW Fit Around a Telepsychiatry Prescribing Policy?
Clarity Health + Wellness may fit a telepsychiatry practice when the clinician's policy or practice model creates a need for a professional New York base, private clinical rooms, or occasional in-person access.
CHW provides practice infrastructure. It does not decide when a member should prescribe, review a member's PMP, manage EPCS credentials, create the member's controlled-substance policy, take over the clinician's documentation obligations, or store controlled substances for members under its ordinary membership model.
Virtual Members can book rooms when in-person clinical space is needed. Professional-address use and mail support are subject to the membership agreement and applicable requirements, and address use begins according to the contractual arrangement. CHW does not guarantee third-party acceptance of an address for a particular purpose.
The practical test is whether the location, room access, and practice relationship fit the needs identified in the clinician's own policy and regulatory analysis.
A Good Prescribing Policy Makes Difficult Decisions More Consistent
A controlled-substance policy is most useful when it tells the practice what to check, who decides, how exceptions and urgent issues are routed, and what gets recorded. It should separate external requirements from internal rules and preserve patient-specific clinical judgment. When an unusual request arrives, the practice already has a decision path.
If your policy identifies a need for a professional New York location or bookable private rooms for occasional in-person care, compare CHW's Virtual and On-Demand membership options with the professional-location and room-access needs you identified in your own analysis.
Frequently Asked Questions About Controlled-Substance Prescribing Policies for Telepsychiatry Practices
-
It should define prescribing authority, patient identity and location verification, consent and patient communication, telemedicine and in-person evaluation checks, PMP and EPCS dependencies, monitoring, refill procedures, emergency routing, documentation, escalation, and policy review.
-
The practice should include current-location verification as one of its prescribing checkpoints. The clinician can then determine which licensure, prescribing, and telemedicine requirements apply to that encounter.
-
New York permits telemedicine or telehealth prescribing without an in-person evaluation under a listed exception when the prescribing is consistent with state requirements and applicable DEA rules. Current federal temporary telemedicine flexibilities extend through December 31, 2026. Practices should verify the rule in effect when prescribing.
-
It should define how the reason, remaining medication, prior history, PMP information where required, and clinical circumstances are reviewed. An early request should not create an automatic approval or automatic refusal.
-
No automatic replacement rule should be assumed. The policy can state that the prescriber will review the medication, circumstances, clinical risk, prior pattern, PMP information where applicable, and any supporting information before deciding what is appropriate.
-
It should define when a medication problem leaves the routine refill process and how it is routed for timely clinical review. Possible withdrawal, acute safety concerns, marked clinical deterioration, or a need for emergency or higher-level care should follow the practice's urgent or emergency procedures rather than an ordinary refill channel.
Educational Disclaimer
This article provides general educational information and is not legal advice, regulatory advice, or individualized professional guidance. Requirements can vary based on profession, prescribing authority, controlled-substance activities, patient locations, state authorization, practice structure, and individual circumstances. Clinicians should verify current requirements directly with applicable federal and New York authorities and qualified legal or regulatory counsel when appropriate.
About Clarity Health + Wellness
Clarity Health + Wellness is a therapist-led office and membership space in Midtown Manhattan founded by Dr. Logan Jones. Located on Fifth Avenue, CHW offers flexible therapy room rentals, professional memberships, and a more connected private-practice experience for mental health clinicians and aligned wellness professionals who want a space that feels polished, calm, and clinically appropriate without taking on the burden of a traditional lease.
Members can choose from On-Demand, Virtual, and Club options depending on how they practice. Offerings include furnished therapy suites, flexible room booking through Skedda, a compliant NYC business address for eligible professional use, and access to community features such as events, networking, and Clarity Chats through Club Membership.
Clarity Health + Wellness is especially known for combining sophisticated design, flexibility, and therapist-centered community in a way that supports both client experience and long-term practice growth.
Last reviewed: September 2026